Cognex (CGNX) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.45
- Estimate
- $0.42
- Surprise
- +5.9%
- Revenue (period 2026-07-05)
- $291.3M
- Score today
- 6.6/10
Revenue source: xbrl.
How the report landed
Cognex (CGNX) beat the $0.42 estimate with diluted EPS of $0.45 — a clear 5.9% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CGNX Buy (Wait) at 6.6/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +5.9% surprise compares with a +19.9% four-quarter average. Next scheduled report: 2026-10-28.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.6 in RISK_OFF)
- Strong earnings beat streak (4/4)
What argues against it
- Sector modifier (Technology): -0.8
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $59.36
- Entry target
- $58.84
- Price target
- $72.05
- Stop
- $54.84
- Upside to target
- +21.4%
- Reward-to-risk
- 3.0:1
The stock trades at 61.8× trailing but 31.7× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.
CGNX at TrendMatrix's latest read
Technology names get repriced on forward expectations more than trailing prints — a quarter here is read through next-year growth and multiple, not the EPS line alone.
- Industry
- Scientific & Technical Instruments
- Market cap
- $10.80B
- P/E (fwd)
- 31.7
- P/E (ttm)
- 61.8
- 52-week range
- $34.60–$72.88
- Off 52-week high
- 18.6%
- RSI (14)
- 54
- Volume vs avg
- 1.18×
- Score today
- 6.6/10